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C9orf72 Repeat Expansions as
Genetic Modifiers for Depression
in Spinocerebellar Ataxias
The genetic interactions between pathological repeat
expansions have been of major interests in neurodegenera-
tive disorders. Recently, pathogenic C9orf72 repeat expan-
sions, a main genetic cause of amyotrophic lateral sclerosis
and frontotemporal dementia, and pathogenic ATXN2
repeat expansions, the causative gene for spinocerebellar
ataxia (SCA) type 2, are reported to coexist in a single fami-
ly with ataxia.1 Therefore, this observation raises an interest-
ing possibility that C9orf72 repeat expansions could be
genetic modifiers in CAG-repeat SCAs and might influence
the disease progression.
Therefore, we studied 277 patients with SCA1, 2, 3, and
6 from the Clinical Research Consortium for Spinocerebellar
Ataxias cohort,2 and we determined the C9orf72 repeat
length as previously described.3 The Scale for Assessment
and Rating of Ataxia and the 9-item Patient Health Ques-
tionnaire were used to measure the severity of ataxia and
depression, respectively. We studied the rate of ataxia and
depression progression using generalized estimating equation
to test whether the intermediate repeats of C9orf72 were
associated with ataxia or depression progression in SCAs. As
described previously, full repeat expansions of C9orf72 were
defined as 31 hexanucleotide repeats, whereas intermediate
repeat expansions were 8-30.3-5
We identified 7 patients (3 of 51 SCA1, 2 of 58 SCA2, 1
of 109 SCA3, 1 of 59 SCA6) with pathogenic C9orf72
repeat expansions. None of the 7 cases had motor neuron
disease, but they had various degrees of motor neuron signs
(Table 1). When compared with the cognitively normal con-
trol population (the original paper cites 1039 Europeans and
620 African Americans),5 the frequencies of expanded
C9orf72 repeats in our cohort were significantly higher in
SCA1, 2, and 6, but not in SCA3 (Supplemental Table 1).
Of SCA patients, 40% carry intermediate C9orf72 repeat
expansions, and the demographic and clinical features of
SCA patients with normal and intermediate alleles of
C9orf72 are shown in Supplemental Table 2. Intermediate
C9orf72 repeat expansions did not influence the rate of
ataxia progression but were associated with different rates
of depressive symptom progression in SCA1, 3, and 6
(SCA1, b 5 21.90, P< .005; SCA3, b 5 3.48, P< .001;
SCA6, b 5 21.72, P< .05; Supplemental Table 3).
In the present study, we identified patients of SCA1, 2, 3,
and 6 who also carried pathogenic C9orf72 repeat expan-
sions. Intermediate C9orf72 repeat expansions might influ-
ence the nonmotor symptom (ie, depression) progression in
SCAs. Our study highlights the genetic interactions between
repeat expansions.
The presence of CAG repeat expansions could interfere
with the DNA repair process,6 which may destabilize
C9orf72 repeat expansions and explain the coexistence of
C9orf72 repeat expansions and expanded CAG repeats.
Because cerebellar pathology could be found in C9orf72-
linked amyotrophic lateral sclerosis, the presence of C9orf72
repeat expansions might affect polyglutamine aggregates
preferentially in the cerebellum or brain stem structures
implicated in depression.
In conclusion, our study provides supporting evidence that
repeat expansions of C9orf72 may be genetic modifiers in
SCAs and perhaps ataxia patients in general.7 Therefore, the
interplay of repeat expansions in 2 different loci may lead to
diverse clinical phenotypes in degenerative cerebellar ataxia.
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7 6 11/23 8/>30 Man 59 12.5 Not
evaluated
None None None None None
SCA, spinocerebellar ataxias; SARA, Scale for Ataxia Rating and Assessment; serial 7s, Serial Sevens Subtraction Test.
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